Artificial intelligence for identification of candidates for device-aided therapy in Parkinson's disease: DELIST-PD study.

Journal: Computers in biology and medicine
PMID:

Abstract

INTRODUCTION: In Parkinson's Disease (PD), despite available treatments focusing on symptom alleviation, the effectiveness of conventional therapies decreases over time. This study aims to enhance the identification of candidates for device-aided therapies (DAT) using artificial intelligence (AI), addressing the need for improved treatment selection in advanced PD stages.

Authors

  • Eric Freire-Álvarez
    Hospital General Universitario de Elche, Alicante, Spain.
  • Inés Legarda Ramírez
    Hospital Universitario Son Espases, Palma de Mallorca, Spain.
  • Rocio García-Ramos
    Departament of Neurology, Instituto de Neurociencias, Hospital Clínico San Carlos, Madrid, Spain.
  • Fátima Carrillo
    Movement Disorders Unit, Neurology and Clinical Neurophysiology department, Instituto de Biomedicina de Sevilla, Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Spain.
  • Diego Santos-García
    Departament of Neurology, Complejo Hospitalario Universitario de A Coruña-INIBIC, A Coruña, Spain.
  • Juan Carlos Gómez-Esteban
    Neurodegenerative Diseases Group, Biobizkaia Health Research Institute, Barakaldo, Spain.
  • Juan Carlos Martínez-Castrillo
    Departament of Neurology, Hospital Universitario Ramón y Cajal, IRYCIS, Madrid, Spain.
  • Irene Martínez-Torres
    Departament of Neurology, Hospital Universitari i Politècnic La Fe, Valencia, Spain.
  • Carlos J Madrid-Navarro
    Departament of Neurology, Hospital Universitario Virgen de las Nieves, Instituto de Investigación Biosanitaria ibs.GRANADA, Granada, Spain.
  • María José Pérez-Navarro
    Departament of Neurology, Hospital Universitario Virgen de las Nieves, Instituto de Investigación Biosanitaria ibs.GRANADA, Granada, Spain.
  • Fuensanta Valero-García
    Hospital Universitario Son Espases, Palma de Mallorca, Spain.
  • Bárbara Vives-Pastor
    Hospital Universitario Son Espases, Palma de Mallorca, Spain.
  • Laura Muñoz-Delgado
    Movement Disorders Unit, Neurology and Clinical Neurophysiology department, Instituto de Biomedicina de Sevilla, Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Spain.
  • Beatriz Tijero
    Neurodegenerative Diseases Group, Biobizkaia Health Research Institute, Barakaldo, Spain; Department of Neurology, Cruces University Hospital-OSAKIDETZA, Barakaldo, Spain.
  • Carlos Morata Martínez
    Departament of Neurology, Hospital Universitari i Politècnic La Fe, Valencia, Spain.
  • José M Valls
    Department of Computer Science, Universidad Carlos III de Madrid, Madrid, Spain.
  • Ricardo Aler
    Department of Computer Science, Universidad Carlos III de Madrid, Madrid, Spain.
  • Inés M Galván
    Department of Computer Science, Universidad Carlos III de Madrid, Madrid, Spain.
  • Francisco Escamilla-Sevilla
    Departament of Neurology, Hospital Universitario Virgen de las Nieves, Instituto de Investigación Biosanitaria ibs.GRANADA, Granada, Spain. Electronic address: francisco.escamilla@sen.es.